In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlordiazepoxid Drug Master File in Korea (Chlordiazepoxid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlordiazepoxid. The MFDS reviews the Chlordiazepoxid KDMF as part of the drug registration process and uses the information provided in the Chlordiazepoxid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlordiazepoxid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlordiazepoxid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlordiazepoxid suppliers with KDMF on PharmaCompass.